Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Evi S. Lianidou"'
Publikováno v:
Diagnostics, Vol 11, Iss 3, p 513 (2021)
In metastatic breast cancer (MBC) the molecular characterization of circulating tumor cells (CTCs) provides a unique tool to understand metastasis-biology and therapy-resistance. We evaluated the prognostic significance of gene expression in EpCAM(+)
Externí odkaz:
https://doaj.org/article/77bdd6495c0b42da9060fc9f571b0eaf
Publikováno v:
Cells, Vol 8, Iss 7, p 652 (2019)
(1) Background: The aim of the study was to evaluate the prognostic significance of EMT-associated (TWIST1) and stem-cell (SC) transcript (CD24, CD44, ALDH1) quantification in EpCAM+ circulating tumor cells (CTCs) of early breast cancer patients. (2)
Externí odkaz:
https://doaj.org/article/0218c5bc2ffc4b4a814affd73226ce44
PDF 111KB, Oligonucleotide sequences of BRMS1 primers used in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00231df22d176085dadb1f2680e7c512
https://doi.org/10.1158/1541-7786.22509121.v1
https://doi.org/10.1158/1541-7786.22509121.v1
Autor:
Matthias F. Froelich, Ettore Capoluongo, Zsolt Kovacs, Simon J. Patton, Evi S. Lianidou, Verena Haselmann
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 60:821-829
Disruptive imaging and laboratory technologies can improve clinical decision processes and outcomes in oncology. However, certain obstacles must be overcome before these technologies can be fully implemented as part of the standard for care. An integ
Autor:
Victoria Tserpeli, Dimitra Stergiopoulou, Dora Londra, Lydia Giannopoulou, Paul Buderath, Ioanna Balgkouranidou, Nikolaos Xenidis, Christina Grech, Eva Obermayr, Robert Zeillinger, Kitty Pavlakis, Theodoros Rampias, Stylianos Kakolyris, Sabine Kasimir-Bauer, Evi S. Lianidou
Publikováno v:
Cancers, Vol 14, Iss 4, p 4 (2022)
Cancers; Volume 14; Issue 1; Pages: 4
Cancers; Volume 14; Issue 1; Pages: 4
Background: Epigenetic alterations in ctDNA are highly promising as a source of novel potential liquid biopsy biomarkers and comprise a very promising liquid biopsy approach in ovarian cancer, for early diagnosis, prognosis and response to treatment.
Autor:
Areti Strati, Martha Zavridou, Dimitrios Paraskevis, Gkikas Magiorkinis, Spyros Sapounas, Pagona Lagiou, Nikolaos S. Thomaidis, Evi S. Lianidou
Publikováno v:
Analytical chemistry. 94(36)
Highly sensitive methodologies for SARS-CoV-2 detection are essential for the control of COVID-19 pandemic. We developed and analytically validated a highly sensitive and specific five-plex one-step RT-ddPCR assay for SARS-CoV-2. We first designed in
Autor:
Victoria, Tserpeli, Dimitra, Stergiopoulou, Dora, Londra, Lydia, Giannopoulou, Paul, Buderath, Ioanna, Balgkouranidou, Nikolaos, Xenidis, Christina, Grech, Eva, Obermayr, Robert, Zeillinger, Kitty, Pavlakis, Theodoros, Rampias, Stylianos, Kakolyris, Sabine, Kasimir-Bauer, Evi S, Lianidou
Publikováno v:
Cancers
Simple Summary In the present study, we examined the methylation status of six gene promoters (BRCA1, CST6, MGMT, RASSF10, SLFN11 and USP44) in high-grade serous ovarian cancer (HGSOC). We evaluated the prognostic significance of DNA methylation of t
Background In metastatic breast cancer (MBC) the molecular characterization of Circulating Tumor Cells (CTCs) provides a unique tool to understand metastasis-biology and therapy-resistance. We evaluated the prognostic significance of gene expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0c877f0ecb95ad4444e90e0629ceb8f
https://doi.org/10.21203/rs.3.rs-56105/v1
https://doi.org/10.21203/rs.3.rs-56105/v1
Publikováno v:
Advances in experimental medicine and biology. 867
Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and as a source of valuable tumor markers. CTCs are rare, and thus their detection, enumeration and molecular characterization are very challengin